美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=BLA209196"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0024-5926-05 0024-5926 HUMAN PRESCRIPTION DRUG ADMELOG insulin lispro INJECTION, SOLUTION INTRAVENOUS; SUBCUTANEOUS 20181019 N/A BLA BLA209196 Sanofi-Aventis U.S. LLC INSULIN LISPRO 100 U/mL 1 VIAL in 1 CARTON (0024-5926-05) / 3 mL in 1 VIAL
0024-5925-05 0024-5925 HUMAN PRESCRIPTION DRUG ADMELOG insulin lispro INJECTION, SOLUTION SUBCUTANEOUS 20171211 N/A BLA BLA209196 Sanofi-Aventis U.S. LLC INSULIN LISPRO 100 U/mL 5 SYRINGE in 1 CARTON (0024-5925-05) / 3 mL in 1 SYRINGE (0024-5925-01)
0024-5925-00 0024-5925 HUMAN PRESCRIPTION DRUG ADMELOG insulin lispro INJECTION, SOLUTION SUBCUTANEOUS 20171211 N/A BLA BLA209196 Sanofi-Aventis U.S. LLC INSULIN LISPRO 100 U/mL 1 SYRINGE in 1 CARTON (0024-5925-00) / 3 mL in 1 SYRINGE
0024-5924-10 0024-5924 HUMAN PRESCRIPTION DRUG ADMELOG insulin lispro INJECTION, SOLUTION INTRAVENOUS; SUBCUTANEOUS 20171211 N/A BLA BLA209196 Sanofi-Aventis U.S. LLC INSULIN LISPRO 100 U/mL 1 VIAL, MULTI-DOSE in 1 CARTON (0024-5924-10) / 10 mL in 1 VIAL, MULTI-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase